Kazia Therapeutics

3 followers


Kazia Therapeutics is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. Headquartered in Sydney, Australia, Kazia Therapeutics collaborates with leading scientists, clinicians, and investors around the world.

Industries

Headquarters

Sydney, Australia

Employees

11-50

Links


Org chart

John Friend
Chief Executive Officer
Robert Kennedy
VP Corporate Relations
Chinar Patel
Quality Assurance Lead

Board & advisors

Alex Matter
Scientific Advisor
Bryce Carmine
Non-Executive Director
Iain Ross
Chairman & Non-Executive Director
Karen Ferrante
Scientific Advisor
Kate Hill
Company Secretary
Murray Brennan
Scientific Advisor
Peter Gunning
Scientific Advisor
Steven Coffey
Non-Executive Director